Perioperative problems in Parkinson's disease and their management: Apomorphine with rectal domperidone

被引:38
作者
GalvezJimenez, N [1 ]
Lang, AE [1 ]
机构
[1] UNIV TORONTO, MORTON & GLORIA SHULMAN MOVEMENT DISORDERS CTR, TORONTO HOSP, TORONTO, ON M5T 2S8, CANADA
关键词
D O I
10.1017/S0317167100038518
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To present guidelines on the use of apomorphine in combination with rectal domperidone in Parkinson's disease (PD) patients undergoing abdominal surgery and to review the perioperative problems encountered in such patients. Background: PD Patients undergoing abdominal surgery present a major therapeutic challenge. Because most antiparkinsonian medications must be withheld until the patient is able to resume oral intake, resulting rigidity and akinesia as well as alterations in gastrointestinal motility, respiratory function and swallowing mechanisms predispose these patients to numerous serious postoperative complications. We have found that parenteral apomorphine in combination with rectal domperidone markedly facilitates the care of these difficult patients. Methods: Presentation of two illustrative cases with review of the literature. Resulted: A standardized protocol using subcutaneous apomorphine and rectal domperidone was used in two PD patients who underwent abdominal surgery. Excellent control of parkinsonian symptomatology ws obtained without side effects. The simplicity of the protocol was emphasized in our second patient who required urgent reoperation; the surgery nursing staff was able to restart the apomorphine immediately without having to wait for neurological follow-up assessment. Conclusions: The use of parenteral apomorphine with rectal domperidone in the immediate postoperative period for patients unable to take oral antiparkinson drugs increases patient comfort, facilitates nursing care and may reduce serious postoperative complications.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 62 条
[1]   RESPIRATION AND SLEEP IN PARKINSONS-DISEASE [J].
APPS, MCP ;
SHEAFF, PC ;
INGRAM, DA ;
KENNARD, C ;
EMPEY, DW .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1985, 48 (12) :1240-1245
[2]  
BOGAARD JM, 1987, B EUR PHYSIOPATH RES, V23, pS417
[3]   APOMORPHINE TEST FOR DOPAMINERGIC RESPONSIVENESS - A DOSE ASSESSMENT STUDY [J].
BONUCCELLI, U ;
PICCINI, P ;
DELDOTTO, P ;
ROSSI, G ;
CORSINI, GU ;
MURATORIO, A .
MOVEMENT DISORDERS, 1993, 8 (02) :158-164
[4]   DOMPERIDONE - A REVIEW OF ITS PHARMACOLOGICAL ACTIVITY, PHARMACOKINETICS AND THERAPEUTIC EFFICACY IN THE SYMPTOMATIC TREATMENT OF CHRONIC DYSPEPSIA AND AS AN ANTIEMETIC [J].
BROGDEN, RN ;
CARMINE, AA ;
HEEL, RC ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1982, 24 (05) :360-400
[5]   CONTINUOUS SUBCUTANEOUS APOMORPHINE AS REPLACEMENT FOR LEVODOPA IN SEVERE PARKINSONIAN-PATIENTS AFTER SURGERY [J].
BROUSSOLLE, E ;
MARION, MH ;
POLLAK, P .
LANCET, 1992, 340 (8823) :859-860
[6]  
CHAUDHURI KR, 1988, LANCET, V2, P1260
[7]  
CHOKROVERTY S, 1988, AUTONOMIC FAILURE, P432
[8]  
CHOKROVERTY S, 1990, MOVEMENT DISORD, P365
[9]   CLINICAL USEFULNESS OF APOMORPHINE IN MOVEMENT-DISORDERS [J].
COLOSIMO, C ;
MERELLO, M ;
ALBANESE, A .
CLINICAL NEUROPHARMACOLOGY, 1994, 17 (03) :243-259
[10]   STRIDOR DURING DYSTONIC PHASES OF PARKINSONS-DISEASE [J].
CORBIN, D ;
WILLIAMS, AC .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (06) :821-822